Research Labs Review: Its Own Terms Say Not For Humans
Research Labs sells peptides labelled for laboratory use — listed as GLP-1 (SG) from $65.99, GLP-2 (TZ) from $52.99, GLP-3 (RT) from $89.99, alongside BPC-157, TB-500, ipamorelin, NAD+ and GHK-Cu. The prices are dramatically below any telehealth programme, which is exactly why people find sites like this while searching for cheaper GLP-1 access. Its own terms of service state the products are strictly for in-vitro laboratory research and not intended for human consumption, therapeutic use, or any clinical application. This review takes that statement seriously.
Verified August 24, 2026. This is not a telehealth provider and is deliberately excluded from our GLP-1 provider rankings. There is no clinician, no prescription and no medical oversight involved. For weight-loss medication see our GLP-1 provider rankings.
Affiliate disclosure: Rx Saver Hub earns a commission if you sign up through links on this page. It does not change what we write — see our disclosure policy.
Verdict: Do not use these products as medication. Research Labs is transparent about what it is — its terms state products are for in-vitro laboratory research only, explicitly not for human or animal consumption, and it disclaims all warranties and requires you to indemnify it for any human use. HPLC purity testing verifies chemical identity; it does not verify sterility or endotoxin content, which is the specific thing that matters for anything injected. There is no prescriber, no dosing guidance, no monitoring and no route to report an adverse event. And a legitimate compounded GLP-1 with a licensed prescriber now starts at $69 a month, which removes most of the cost argument entirely.
What Research Labs Costs
Prices are low, which is the entire reason this market exists. Here is the comparison people are actually making.
| Plan | What you get | Listed | Real cost |
|---|---|---|---|
| GLP-1 (SG) | Semaglutide-class research peptide | From $65.99 | No prescription, no clinician |
| GLP-2 (TZ) | Tirzepatide-class research peptide | From $52.99 | No sterility or endotoxin data |
| GLP-3 (RT) | Retatrutide-class — still investigational | From $89.99 | Not approved anywhere, for anything |
| Licensed telehealth | Compounded, prescribed, monitored | From $69/month | The actual comparison |
The safety gaps are specific, not theoretical
Four of them. Sterility: HPLC verifies what a compound is, not whether it is free of bacteria or bacterial endotoxin — and endotoxin survives sterilisation that kills bacteria. Injecting a non-sterile preparation risks abscess, cellulitis and systemic infection. Dosing: reconstituting lyophilised powder to a target dose requires arithmetic that is easy to get wrong by a factor of ten, with no pharmacist checking. Oversight: nobody screens you for contraindications like a personal or family history of medullary thyroid carcinoma or MEN 2, and nobody is monitoring you. Recourse: there is no adverse event pathway and the terms disclaim liability entirely.
A licensed provider on this site advertises compounded semaglutide at $69 a month with a prescriber, a 503A pharmacy, and a refund if you are not approved. The cost gap that made this market attractive has largely closed.
What the product names are doing
The catalogue uses initialisms rather than drug names — GLP-1 (SG), GLP-2 (TZ), GLP-3 (RT). Those are not established scientific designations. GLP-2 is in fact an entirely different naturally occurring hormone from tirzepatide, so the naming is not even internally consistent as science.
What the convention does accomplish is describing well-known medications without using their names. Anyone shopping for a cheap GLP-1 understands what is meant, while the listing itself avoids the drug names. That is worth noticing as a signal about how the product is expected to be used.
Retatrutide deserves its own warning
The third listing corresponds to a compound still in clinical development. It is not approved by any regulator, anywhere, for any indication — its safety and efficacy profile in humans is still being established by the trials currently running.
Buying an investigational drug outside a trial means taking something whose full side effect profile is not yet characterised, at a dose nobody has established for you, without the monitoring a trial participant receives. That is a materially different proposition from taking a medication with years of post-approval safety data.
What HPLC testing does and does not cover
The site advertises 99 percent-plus HPLC verified purity with a certificate of analysis on every order, and that is a real test. High-performance liquid chromatography identifies a compound and quantifies impurities in the chemical sense.
It says nothing about sterility, bacterial endotoxin, or particulate contamination. For a substance intended to be injected, those are the parameters that determine whether it causes an infection or a systemic inflammatory reaction. Pharmaceutical sterile injectables are tested for exactly these things; a research chemical does not have to be, because nobody is supposed to inject it.
The legitimate options, which are now cheap
The cost argument for this market has weakened considerably. Licensed telehealth providers reviewed on this site now advertise compounded semaglutide from $69 a month and tirzepatide from $119, flat at every dose, with a prescriber, a 503A compounding pharmacy, free shipping and a refund if you are not approved.
If you have insurance that covers weight-loss medication, a covered fill at a retail pharmacy is cheaper still. If not, manufacturer-direct self-pay programmes for FDA-approved products are worth checking before anything else. Those routes all include somebody whose job is to notice if something goes wrong.
Pros and Cons
Strengths
- States its research-use-only status plainly in its terms rather than obscuring it
- Publishes HPLC purity data and includes a certificate of analysis
- Pricing is transparent on the listing pages
Drawbacks
- Its own terms state products are not for human or animal consumption
- HPLC purity does not establish sterility or endotoxin safety for injection
- No prescriber, no dosing guidance, no screening for contraindications
- Sells a compound still in clinical trials and unapproved anywhere
- No adverse event pathway; terms disclaim liability and require indemnification
- Reconstitution errors of tenfold are easy and nobody checks the arithmetic
Who Should Pick It — and Who Shouldn't
Good fit
Nobody buying these as medication. If you genuinely operate a laboratory, you already know how to evaluate a supplier and this review is not aimed at you.
Look elsewhere
Anyone considering this as a cheaper route to a GLP-1. Licensed compounded semaglutide now starts at $69 a month with a prescriber and a refund guarantee — the cost gap that made this route tempting has largely closed.
Frequently Asked Questions
Can I inject research peptides instead of paying for a prescription?
The company's own terms say the products are for in-vitro laboratory research and not for human consumption or clinical use. Beyond the legal framing, the practical gaps are sterility and endotoxin testing that HPLC does not cover, no dosing oversight, no screening for contraindications, and no route to report a problem.
Is research peptide semaglutide the same as prescription semaglutide?
It may be the same molecule and still not be the same product. Pharmaceutical and compounded injectables are prepared under sterility requirements and tested for bacterial endotoxin. Research chemicals are not required to meet those standards, because they are not intended for injection.
What is retatrutide and why is it a concern?
A compound still in clinical development, not approved by any regulator for any use. Its full human safety profile is still being established. Taking an investigational drug outside a trial means no established dose, no monitoring, and no characterised side effect profile.
What is the cheapest legitimate way to get a GLP-1?
If insured, check whether your plan covers weight-loss medication — a covered fill is usually cheapest. If not, compare manufacturer-direct self-pay programmes for FDA-approved products, then licensed compounded telehealth, where prices now start around $69 a month with a prescriber and a refund if you are not approved.
Considering Research Labs?
If cost is what brought you here, compare licensed options first — compounded semaglutide now starts at $69 a month with a prescriber, a 503A pharmacy and a refund guarantee. That is a better deal than it looks next to a research chemical.
More Reviews Like This
Other brands we have reviewed in the same category.
Product listings, purity claims and terms of service read from researchlabs.com on August 24, 2026 and subject to change. The terms of service state products are intended strictly for in-vitro laboratory research and are not intended for human or animal consumption, therapeutic use, diagnostic purposes, or any clinical application. This page is informational and not medical advice. Rx Saver Hub earns a commission on purchases made through links on this page; that has not changed what is written above.